Welcome to our dedicated page for Doximity news (Ticker: DOCS), a resource for investors and traders seeking the latest updates and insights on Doximity stock.
Doximity Inc (DOCS) provides a HIPAA-secure digital platform connecting U.S. healthcare professionals through secure collaboration tools and medical networking features. This news hub offers investors and medical practitioners timely updates about platform developments, regulatory compliance milestones, and strategic partnerships.
Access comprehensive coverage of DOCS' operational updates including product innovations, financial results, and industry partnerships. All content is verified through primary sources to ensure accuracy for investment research and professional decision-making.
Key focus areas include updates on telehealth integrations, physician network expansion, and security protocol enhancements. Users benefit from centralized access to DOCS' regulatory filings, leadership announcements, and technology roadmap developments.
Bookmark this page for streamlined monitoring of Doximity's progress in advancing healthcare collaboration through its cloud-based platform. Check regularly for objective reporting on developments impacting both clinical workflows and long-term corporate strategy.
Doximity (NYSE: DOCS) announced that its telehealth platform, Doximity Dialer, has been awarded the 2023 ‘Best in KLAS’ for the second consecutive year in the Telehealth - Video Conferencing segment. The platform excelled in areas such as culture, loyalty, operations, product, relationship, and value, showcasing its user-friendly experience. A record 375,000 unique providers utilized Dialer last quarter, enhancing patient care through HIPAA-compliant features like one-click video visits. The KLAS report recognizes top healthcare IT solutions based on extensive evaluations, emphasizing Doximity's significant role in advancing digital healthcare.
Doximity, Inc. (NYSE: DOCS) reported total revenues of $115.3 million for Q3 fiscal 2023, reflecting an 18% increase year-over-year. Operating cash flow reached $48.7 million, up 78%, while free cash flow surged to $47.5 million, marking an 85% growth. However, net income decreased to $33.5 million from $55.6 million, resulting in a net income margin of 29%. For Q4, the company forecasts revenue of $109.6 million to $110.6 million and maintains a positive outlook for FY 2024, projecting revenues over $500 million.
Doximity, Inc. (NYSE:DOCS) announced it will report its fiscal third-quarter financial results for the period ending
Doximity, Inc. (NYSE: DOCS) has announced that CFO Anna Bryson will participate in a fireside chat at the Raymond James Technology Investor Conference on December 5, 2022, at 10:20 a.m. Eastern Time. Doximity is a leading digital platform for U.S. medical professionals, with over 80% of U.S. physicians as members. The platform offers various digital tools to enhance productivity, allowing members to collaborate, stay updated on medical news, manage careers, and conduct virtual patient visits. Visit www.doximity.com for more information.
Doximity, Inc. (NYSE: DOCS) reported Q2 2023 total revenues of $102.2 million, a 29% year-over-year increase. Operating cash flow rose to $39.5 million (+106%), with free cash flow reaching $37.7 million (+109%). Net income fell to $26.3 million (margin of 26%) compared to the previous year, while non-GAAP net income was $36.2 million (35% margin). Doximity projects Q3 2023 revenue between $110.7 million and $111.7 million, affirming full-year revenue guidance of $424.0 million to $432.0 million. A $70 million stock repurchase program was also authorized.
Doximity, Inc. (NYSE:DOCS) announced it will report its financial results for the second quarter ending September 30, 2022, after market close on November 10, 2022. A conference call and webcast will be held at 2:00 p.m. PT (5:00 p.m. ET) to discuss these results. Doximity is a leading digital platform for U.S. medical professionals, boasting over 80% membership among U.S. physicians across all specialties, providing tools for collaboration, career management, and virtual patient visits.
Salvo Health has launched a virtual health clinic aimed at addressing chronic gut conditions for over 60 million Americans. The company recently secured $10.5 million in seed funding led by Threshold Ventures, along with Torch Capital and Felicis. Salvo Health offers a comprehensive care model, Whole Self Science, that integrates various health disciplines to provide personalized treatment plans. Their approach includes unlimited access to a dedicated care team, emphasizing root cause treatment over conventional methods. The company plans to expand its services across the U.S.
Doximity (NYSE: DOCS) recently appointed Phoebe L. Yang to its Board of Directors. Ms. Yang brings extensive health system and cloud expertise, having held key roles at Amazon Web Services and CommonSpirit Health. She was recognized as one of Modern Healthcare's Top 100 Most Influential People in Healthcare. Doximity CEO Jeff Tangney emphasized her dual expertise in healthcare and technology as pivotal for the company's growth and innovation in clinical tools. Yang expressed enthusiasm about contributing to Doximity's mission of enhancing physician productivity.
Doximity reported Q1 fiscal 2023 revenues of $90.6 million, a 25% increase year-over-year, alongside an operating cash flow of $44.8 million, up 35%. The net income of $22.4 million marked a decrease from the previous year's $26.3 million, leading to a margin drop from 36% to 25%. The company maintains a positive outlook, projecting Q2 revenue between $99.5 million and $100.5 million and adjusting full-year revenue guidance to between $424.0 million and $432.0 million.
FAQ
What is the current stock price of Doximity (DOCS)?
What is the market cap of Doximity (DOCS)?
